Intermediate Malignant and Malignant Tumors of Soft Tissue Featuring a Spindle Cell Morphology

Angelo Paolo Dei Tos

doi:10.1017/9781316535097.006

Chapter 4 - Intermediate Malignant and Malignant Tumors of Soft Tissue Featuring a Spindle Cell Morphology

Published online by Cambridge University Press: 10 May 2019

Angelo Paolo Dei Tos

Marta Sbaraglia and

Angelo Paolo Dei Tos

Show author details

Angelo Paolo Dei Tos: Affiliation:
Università degli Studi di Padova, Italy

Book contents

Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Type: Chapter
Information: Soft Tissue Sarcomas
A Pattern-Based Approach to Diagnosis
, pp. 71 - 218

DOI: https://doi.org/10.1017/9781316535097.006 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Primary Sources

Abbott, JJ, Erickson-Johnson, M, Wang, X, Nascimento, AG, Oliveira, AM. Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans. Mod Pathol. 2006;19:1512–18.Google Scholar

Abbott, JJ, Oliveira, AM, Nascimento, AG. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans. Am J Surg Pathol. 2006;30:436–43.Google Scholar

Calonje, E, Fletcher, CD. Aneurysmal benign fibrous histiocytoma: clinicopathological analysis of 40 cases of a tumour frequently misdiagnosed as a vascular neoplasm. Histopathology. 1995;26:323–31.Google Scholar

Calonje, E, Fletcher, CD. Myoid differentiation in dermatofibrosarcoma protuberans and its fibrosarcomatous variant: clinicopathologic analysis of 5 cases. J Cutan Pathol. 1996;23:30–6.Google Scholar

Calonje, E, Mentzel, T, Fletcher, CD. Cellular benign fibrous histiocytoma. Clinicopathologic analysis of 74 cases of a distinctive variant of cutaneous fibrous histiocytoma with frequent recurrence. Am J Surg Pathol. 1994;18:668–76.CrossRef Google Scholar PubMed

Doyle, LA, Fletcher, CD. Metastasizing “benign” cutaneous fibrous histiocytoma: a clinicopathologic analysis of 16 cases. Am J Surg Pathol. 2013;37:484–95.CrossRef Google Scholar

Doyle, LA, Mariño-Enriquez, A, Fletcher, CD, Hornick, JL. ALK rearrangement and overexpression in epithelioid fibrous histiocytoma. Mod Pathol. 2015;28:904–12.Google Scholar

Fiore, M, Miceli, R, Mussi, C, et al. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol. 2005;23:7669–75.Google Scholar

Kaddu, S, McMenamin, ME, Fletcher, CD. Atypical fibrous histiocytoma of the skin: clinicopathologic analysis of 59 cases with evidence of infrequent metastasis. Am J Surg Pathol. 2002;26:35–46.CrossRef Google Scholar PubMed

McArthur, GA, Demetri, GD, van Oosterom, A, et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225. J Clin Oncol. 2005;23:866–73.CrossRef Google Scholar PubMed

Mentzel, T, Beham, A, Katenkamp, D, Dei Tos, AP, Fletcher, CD. Fibrosarcomatous (“high-grade”) dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance. Am J Surg Pathol. 1998;22:576–87.CrossRef Google Scholar PubMed

Mentzel, T, Schärer, L, Kazakov, DV, Michal, M. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases. Am J Dermatopathol. 2007;29:443–8.CrossRef Google Scholar PubMed

Reimann, JD, Fletcher, CD. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases. Am J Surg Pathol. 2007;31:1371–7.CrossRef Google Scholar

Singh Gomez, C, Calonje, E, Fletcher, CD. Epithelioid benign fibrous histiocytoma of skin: clinico-pathological analysis of 20 cases of a poorly known variant. Histopathology. 1994;24:123–9.Google Scholar PubMed

Stacchiotti, S, Astolfi, A, Gronchi, A, et al. Evolution of dermatofibrosarcoma protuberans to dfsp-derived fibrosarcoma: an event marked by epithelial-mesenchymal transition-like process and 22q loss. Mol Cancer Res. 2016;14:820–9.CrossRef Google Scholar PubMed

Stacchiotti, S, Pantaleo, MA, Negri, T, et al. Efficacy and biological activity of imatinib in metastatic dermatofibrosarcoma protuberans (DFSP). Clin Cancer Res. 2016;22:837–46CrossRef Google Scholar PubMed

Takahira, T, Oda, Y, Tamiya, S, et al. Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB mRNA expression in dermatofibrosarcoma protuberans. Mod Pathol. 2007;20:668–75.Google Scholar

Terrier-Lacombe, MJ, Guillou, L, Maire, G, et al. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data. A study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol. 2003;27:27–39.Google Scholar

Woodruff, JM. Pathology of the major peripheral nerve sheath neoplasms. Monogr Pathol. 1996;38:129–61.Google Scholar PubMed

Secondary Sources

Al-Ibraheemi, A, Martinez, A, Weiss, SW, et al. Fibrous hamartoma of infancy: a clinicopathologic study of 145 cases, including 2 with sarcomatous features. Mod Pathol. 2017;30:474–85.CrossRef Google Scholar PubMed

Dymock, RB, Allen, PW, Stirling, JW, Gilbert, EF, Thornbery, JM. Giant cell fibroblastoma. A distinctive, recurrent tumor of childhood. Am J Surg Pathol. 1987;11:263–71.Google Scholar

Enzinger, FM. Fibrous hamartoma of infancy. Cancer. 1965 Feb;18:241–8.3.0.CO;2-C>CrossRef Google Scholar PubMed

Fetsch, JF, Miettinen, M, Laskin, WB, Michal, M, Enzinger, FM. A clinicopathologic study of 45 pediatric soft tissue tumors with an admixture of adipose tissue and fibroblastic elements, and a proposal for classification as lipofibromatosis. Am J Surg Pathol. 2000;24:1491–500.Google Scholar

Fletcher, CD. Giant cell fibroblastoma of soft tissue: a clinicopathological and immunohistochemical study. Histopathology. 1988;13:499–508.Google Scholar

Fletcher, CD, Powell, G, van Noorden, S, McKee, PH. Fibrous hamartoma of infancy: a histochemical and immunohistochemical study. Histopathology. 1988 Jan;12(1):65–74.Google Scholar

Jha, P, Moosavi, C, Fanburg-Smith, JC. Giant cell fibroblastoma: an update and addition of 86 new cases from the Armed Forces Institute of Pathology, in honor of Dr. Franz M. Enzinger. Ann Diagn Pathol. 2007;11:81–8.Google Scholar

Shmookler, BM, Enzinger, FM, Weiss, SW. Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans. Cancer. 1989;64:2154–61.Google Scholar

Antonescu, CR, Dal Cin, P, Nafa, K, et al. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer. 2007;46:1051–60.CrossRef Google Scholar PubMed

Costa, MJ, Weiss, SW. Angiomatoid malignant fibrous histiocytoma. A follow-up study of 108 cases with evaluation of possible histologic predictors of outcome. Am J Surg Pathol. 1990;14:1126–32.CrossRef Google Scholar PubMed

Enzinger, FM. Angiomatoid malignant fibrous histiocytoma: a distinct fibrohistiocytic tumor of children and young adults simulating a vascular neoplasm. Cancer. 1979;44:2147–57.Google Scholar

Fanburg-Smith, JC, Miettinen, M. Angiomatoid “malignant” fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype. Hum Pathol. 1999;30:1336–43.Google Scholar

Fletcher, CD. Angiomatoid “malignant fibrous histiocytoma”: an immunohistochemical study indicative of myoid differentiation. Hum Pathol. 1991;22:563–8.Google Scholar

Rossi, S, Szuhai, K, Ijszenga, M, et al. EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma. Clin Cancer Res. 2007;13:7322–8.CrossRef Google Scholar PubMed

Schaefer, IM, Fletcher, CD. Myxoid variant of so-called angiomatoid “malignant fibrous histiocytoma”: clinicopathologic characterization in a series of 21 cases. Am J Surg Pathol. 2014;38:816–23.Google Scholar

Thway, K, Nicholson, AG, Wallace, WA, et al. Endobronchial pulmonary angiomatoid fibrous histiocytoma: two cases with EWSR1-CREB1 and EWSR1-ATF1 fusions. Am J Surg Pathol. 2012;36:883–8.Google Scholar

Thway, K, Stefanaki, K, Papadakis, V, Fisher, C. Metastatic angiomatoid fibrous histiocytoma of the scalp, with EWSR1-CREB1 gene fusions in primary tumor and nodal metastasis. Hum Pathol. 2013;44:289–93.Google Scholar

Weinreb, I, Rubin, BP, Goldblum, JR. Pleomorphic angiomatoid fibrous histiocytoma: a case confirmed by fluorescence in situ hybridization analysis for EWSR1 rearrangement. J Cutan Pathol. 2008;35:855–60.Google Scholar

Allen, PW. Nodular fasciitis. Pathology. 1972 Jan;4(1):9–26.Google Scholar

Antonescu, CR, Sung, YS, Zhang, L, Agaram, NP, Fletcher, CD. Recurrent SRF-RELA fusions define a novel subset of cellular myofibroma/myopericytoma: a potential diagnostic pitfall with sarcomas with myogenic differentiation. Am J Surg Pathol. 2017;41:677–84.Google Scholar

Beham, A, Badve, S, Suster, S, Fletcher, CD. Solitary myofibroma in adults: clinicopathological analysis of a series. Histopathology. 1993;22:335–41.Google Scholar

Chan, JY, Gooi, Z, Wong, EW, et al. Low-grade myofibroblastic sarcoma: A population-based study. Laryngoscope. 2017;127:116–12.CrossRef Google Scholar PubMed

Fletcher, CD, Stirling, RW. Intranodal myofibroblastoma presenting in the submandibular region: evidence of a broader clinical and histological spectrum. Histopathology. 1990;16:287–93.Google Scholar

Gronchi, A, Colombo, C, Le Péchoux, C, et al. Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm – a position paper from the Italian and the French Sarcoma Group. Ann Oncol. 2014;25:578–83.Google Scholar

Hung, YP, Fletcher, CDM. Myopericytomatosis: clinicopathologic analysis of 11 cases with molecular identification of recurrent PDGFRB alterations in myopericytomatosis and myopericytoma. Am J Surg Pathol. 2017;41:1034–104.Google Scholar

Le Guellec, S, Soubeyran, I, Rochaix, P, et al. CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics. Mod Pathol. 2012;25:1551–8.Google Scholar

McMenamin, ME, Fletcher, CD. Malignant myopericytoma: expanding the spectrum of tumours with myopericytic differentiation. Histopathology. 2002;41:450–60.CrossRef Google Scholar PubMed

Mentzel, T, Calonje, E, Nascimento, AG, Fletcher, CD. Infantile hemangiopericytoma versus infantile myofibromatosis. Study of a series suggesting a continuous spectrum of infantile myofibroblastic lesions. Am J Surg Pathol. 1994;18:922–30.Google Scholar

Mentzel, T, Dei Tos, AP, Sapi, Z, Kutzner, H. Myopericytoma of skin and soft tissues: clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol. 2006;30:104–13.Google Scholar

Mentzel, T, Dry, S, Katenkamp, D, Fletcher, CD. Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors. Am J Surg Pathol. 1998;22:1228–38.Google Scholar

Suster, S, Rosai, J. Intranodal hemorrhagic spindle-cell tumor with “amianthoid” fibers. Report of six cases of a distinctive mesenchymal neoplasm of the inguinal region that simulates Kaposi’s sarcoma. Am J Surg Pathol. 1989;13:347–57.Google Scholar

Weiss, SW, Gnepp, DR, Bratthauer, GL. Palisaded myofibroblastoma. A benign mesenchymal tumor of lymph node. Am J Surg Pathol. 1989;13:341–6.CrossRef Google Scholar PubMed

Bahrami, A, Weiss, SW, Montgomery, E, et al. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia. Am J Surg Pathol. 2009;33:1348–54.Google Scholar

Folpe, AL, Fanburg-Smith, JC, Billings, SD, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol. 2004;28:1–30.Google Scholar

Lee, JC, Jeng, YM, Su, SY, et al. Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour. J Pathol. 2015;235:539–45.Google Scholar

Lee, JC, Su, SY, Changou, CA, et al. Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors. Mod Pathol. 2016;29:1335–46.Google Scholar

Salassa, RM, Jowsey, J, Arnaud, CD. Hypophosphatemic osteomalacia associated with “nonendocrine” tumors. N Engl J Med. 1970;283:65–70.Google Scholar

Antonescu, CR, Romeo, S, Zhang, L, et al. Dedifferentiation in gastrointestinal stromal tumor to an anaplastic KIT-negative phenotype: a diagnostic pitfall: morphologic and molecular characterization of 8 cases occurring either de novo or after imatinib therapy. Am J Surg Pathol. 2013;37:385–92.Google Scholar

Boikos, SA, Pappo, AS, Killian, JK, et al. Molecular subtypes of KIT/PDGFRA wild-type gastrointestinal stromal tumors: a report from the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. JAMA Oncol. 2016;2:922–8.Google Scholar

Brenca, M, Rossi, S, Polano, M, et al. Transcriptome sequencing identifies ETV6-NTRK3 as a gene fusion involved in GIST. J Pathol. 2016;238:543–9.Google Scholar

Corless, CL, Schroeder, A, Griffith, D, et al. PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib. J Clin Oncol. 2005;3:5357–64.Google Scholar

Dei Tos, AP. The reappraisal of GIST: from Stout to the KIT revolution. Virchows Arch. 2003;443:421–428.Google Scholar

Demetri, GD, Reichardt, P, Kang, YK, et al. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2013;381:295–302.Google Scholar

Demetri, GD, van Oosterom, AT, Garrett, CR, et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet. 2006;14;368:1329–38.Google Scholar

Fletcher, CD, Berman, JJ, Corless, C, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol, 2002;33:459–65.Google Scholar

Folpe, AL, Fanburg-Smith, JC, Miettinen, M, Weiss, SW. Atypical and malignant glomus tumors: analysis of 52 cases, with a proposal for the reclassification of glomus tumors. Am J Surg Pathol. 2001;25:1–12.Google Scholar

Gasparotto, D, Rossi, S, Polano, M, et al. Quadruple-negative GIST is a sentinel for unrecognized neurofibromatosis type 1 syndrome. Clin Cancer Res. 2017;23:273–82.Google Scholar

Heinrich, MC, Corless, CL, Blanke, CD, et al. Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J Clin Oncol. 2006;24:4764–74.Google Scholar

Heinrich, MC, Corless, CL, Duensing, A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299:708–10.Google Scholar

Hirota, S, Isozaki, K, Moriyama, Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998;279:577–80.Google Scholar

Janeway, KA, Kim, SY, Lodish, M, et al. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci U S A. 2011;108:314–18.Google Scholar

Joensuu, H, Roberts, PJ, Sarlomo-Rikala, M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumour. N Engl J Med. 2001;344:1052–6.Google Scholar

Joensuu, H, Vehtari, A, Riihimäki, J, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 2012;13:265–74.Google Scholar

Kay, S, Callahan, WP Jr, Murray, MR, Randall, HT, Stout, AP. Glomus tumors of the stomach. Cancer. 1951;4:726–36.Google Scholar

Kindblom, L-G, Remotti, HE, Aldenborg, F, Meis-Kindblom, JM. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152:1259–69.Google Scholar PubMed

Lasota, J, Wang, ZF, Sobin, LH, Miettinen, M. Gain-of-function PDGFRA mutations, earlier reported in gastrointestinal stromal tumors, are common in small intestinal inflammatory fibroid polyps. A study of 60 cases. Mod Pathol. 2009;22:1049–56.CrossRef Google Scholar PubMed

Liegl, B, Bennett, MW, Fletcher, CD. Microcystic/reticular schwannoma: a distinct variant with predilection for visceral locations. Am J Surg Pathol. 2008;32:1080–7.Google Scholar

Makhlouf, HR, Ahrens, W, Agarwal, B, et al. Synovial sarcoma of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 10 cases. Am J Surg Pathol. 2008;32:275–81.Google Scholar

Mason, EF, Hornick, JL. Conventional risk stratification fails to predict progression of succinate dehydrogenase-deficient gastrointestinal stromal tumors: a clinicopathologic study of 76 cases. Am J Surg Pathol. 2016;40:1616–21.Google Scholar

Matyakhina, L, Bei, TA, McWhinney, SR, et al. Genetics of Carney triad: recurrent losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. J Clin Endocrinol Metab. 2007;92:2938–43Google Scholar

Miettinen, M, Felisiak-Golabek, A, Wang, Z, Inaguma, S, Lasota, J. GIST manifesting as a retroperitoneal tumor: clinicopathologic immunohistochemical, and molecular genetic study of 112 cases. Am J Surg Pathol. 2017;41:577–85.Google Scholar

Miettinen, M, Furlong, M, Sarlomo-Rikala, M, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol. 2001;25:1121–33.Google Scholar

Miettinen, M, Lasota, J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466–78.Google Scholar

Miettinen, M, Makhlouf, HR, Sobin, LH, Lasota, J. Plexiform fibromyxoma: a distinctive benign gastric antral neoplasm not to be confused with a myxoid GIST. Am J Surg Pathol. 2009;33:1624–32.Google Scholar

Miettinen, M, Sarlomo-Rikala, M, Sobin, LH, Lasota, J. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol. 2000;24:1339–52.Google Scholar

Miettinen, M, Wang, ZF, Lasota, J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol. 2009;33:1401–8.Google Scholar

Novelli, M, Rossi, S, Rodriguez-Justo, M, et al. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours. Histopathology. 2010;57:259–70.Google Scholar

Pasini, B, McWhinney, SR, Bei, T, et al. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet. 2008;16:79–88.CrossRef Google Scholar PubMed

Romeo, S, Rossi, S, Acosta Marín, M, at al. Primary synovial sarcoma (SS) of the digestive system: a molecular and clinicopathological study of fifteen cases. Clin Sarcoma Res. 2015;5:7.Google Scholar

Rossi, S, Gasparotto, D, Miceli, R, et al. KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study. Am J Surg Pathol. 2015;39:922–30.Google Scholar

Rossi, S, Gasparotto, D, Toffolatti, L, et al. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. Am J Surg Pathol. 2010;34:1480–91.Google Scholar

Rossi, S, Miceli, R, Messerini, L, et al. Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables. Am J Surg Pathol. 2011;35:1646–56.Google Scholar

Rubin, BP, Heinrich, MC, Corless, CL. Gastrointestinal stromal tumour. Lancet. 2007;369:1731–41.CrossRef Google Scholar PubMed

Spans, L, Fletcher, CD, Antonescu, CR, et al. Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma. J Pathol. 2016;239:335–43.Google Scholar

Takahashi, Y, Shimizu, S, Ishida, T, et al. Plexiform angiomyxoid myofibroblastic tumor of the stomach. Am J Surg Pathol. 2007;31:724–8.Google Scholar

Wagner, AJ, Remillard, SP, Zhang, YX, et al. Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors. Mod Pathol. 2013;26:289–94.Google Scholar

West, RB, Corless, CL, Chen, X, et al. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am J Pathol. 2004;165:107–13.CrossRef Google Scholar PubMed

Bell, SW, Kempson, RL, Hendrickson, MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994;18:535–58.Google Scholar

Dei Tos, AP, Maestro, R, Doglioni, C, et al. Tumor suppressor genes and related molecules in leiomyosarcoma. Am J Pathol. 1996;148:1037–45.Google Scholar

De Sain Aubain Somerhausen, N, Fletcher, CDM. Leiomyosarcoma of soft tissue in children: clinicopathologic analysis of 20 cases. Am J Surg Pathol. 1999;23:755–63.Google Scholar

Deyrup, AT, Lee, VK, Hill, CE, et al. Epstein-Barr virus-associated smooth muscle tumors are distinctive mesenchymal tumors reflecting multiple infection events: a clinicopathologic and molecular study of 29 tumors from 19 patients. Am J Surg Pathol. 2006;30:75–82.Google Scholar

Fletcher, CD, Kilpatrick, SE, Mentzel, T. The difficulty in predicting behavior of smooth-muscle tumors in deep soft tissue. Am J Surg Pathol. 1995;19:116–17.Google Scholar

Kilpatrick, SE, Mentzel, T, Fletcher, CD. Leiomyoma of deep soft tissue. Clinicopathologic analysis of a series. Am J Surg Pathol. 1994;18:576–82.Google Scholar

Mandhal, N, Fletcher, CDM, Dal cin, P, et al. Comparative cytogenetic study of spindle cell and pleomorphic leiomyosarcoma of soft tissue: a report from the CHAMP study group. Cancer Genet Cytogenet. 2000;116:66–73.Google Scholar

Massi, D, Franchi, A, Alos, L, et al. Primary cutaneous leiomyosarcoma: clinicopathological analysis of 36 cases. Histopathology. 2010;56:251–62.Google Scholar

Mentzel, T, Calonje, E, Fletcher, CD. Leiomyosarcoma with prominent osteoclast-like giant cells. Analysis of eight cases closely mimicking the so-called giant cell variant of malignant fibrous histiocytoma. Am J Surg Pathol. 1994;18:258–65.Google Scholar

Merchant, W, Calonje, E, Fletcher, CD. Inflammatory leiomyosarcoma: a morphological subgroup within the heterogeneous family of so-called inflammatory malignant fibrous histiocytoma. Histopathology. 1995;27:525–32.Google Scholar

Miettinen, M. Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis. Mod Pathol. 2014;27 Suppl 1:S17–29.Google Scholar

Oda, Y, Miyajima, K, Kawaguchi, K, et al. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma. Am J Surg Pathol. 2001;25:1030–8.Google Scholar

Rubin, BP, Fletcher, CD. Myxoid leiomyosarcoma of soft tissue: an underrecognized variant. Am J Surg Pathol. 2000;24:927–36.Google Scholar

Wile, AG, Evans, HL, Romsdhal, MM. Leiomyosarcoma of soft tissue a clinicopathologic study. Cancer. 1981;48:1022–32.Google Scholar

Chan, JKC. Solitary fibrous tumor – everywhere, and a diagnosis in vogue. Histopathology. 1997;31:568–76.CrossRef Google Scholar

Chilosi, M, Facchetti, F, Dei Tos, AP, et al. Bcl-2 expression in pleural and extrapleural solitary fibrous tumours. J Pathol. 1997;181:362–7.Google Scholar

Chmielecki, J, Crago, AM, Rosenberg, M, et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet. 2013 45:131–2.Google Scholar

Collini, P, Negri, T, Barisella, M, et al. High-grade sarcomatous overgrowth in solitary fibrous tumors: a clinicopathologic study of 10 cases. Am J Surg Pathol. 2012;36:1202–15.CrossRef Google Scholar PubMed

Dei Tos, AP, Seregard, S, Calonje, E, et al. Giant cell angiofibroma. A distinctive orbital tumor in adults. Am J Surg Pathol. 1995;19:1286–93.Google Scholar

Demicco, EG, Park, MS, Araujo, DM, et al. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Mod Pathol. 2012;25:1298–306.Google Scholar

Demicco, EG, Wagner, MJ, Maki, RG, et al. Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model. Mod Pathol. 2017;30:1433–42.Google Scholar

de Saint Aubain Somerhausen, N, Rubin, BP, Fletcher, CDM. Myxoid solitary fibrous tumor: a study of seven cases with emphasis on differenttial diagnosis. Mod Pathol. 1999;12:463–71.Google Scholar

Dorfman, DM, To, K, Dickersin, GR, et al. Solitary fibrous tumor of the orbit. Am J Surg Pathol. 1994;18:281–7.CrossRef Google Scholar PubMed

Doyle, LA, Fletcher, CD. Predicting behavior of solitary fibrous tumor: are we getting closer to more accurate risk assessment? Ann Surg Oncol. 2013;20:4055–6.Google Scholar

Doyle, LA, Vivero, M, Fletcher, CD, Mertens, F, Hornick, JL. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol. 2014;27:390–5.Google Scholar

England, DM, Hochholzer, L, McCarthy, MJ. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol. 1989;13:640–58.Google Scholar

Fritchie, KJ, Jin, L, Rubin, BP, et al. NAB2-STAT6 gene fusion in meningeal hemangiopericytoma and solitary fibrous tumor. J Neuropathol Exp Neurol. 2016;75:263–71.Google Scholar

Gengler, C, Guillou, L. Solitary fibrous tumour and haemangiopericytoma: evolution of a concept. Histopathology. 2006;48:63–74.Google Scholar

Gleason, BC, Fletcher, CD. Deep “benign” fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential. Am J Surg Pathol. 2008;32:354–62.Google Scholar

Gold, JS, Antonescu, CR, Hajdu, C, et al. Clinicopathologic correlates of solitary fibrous tumors. Cancer. 2002;15:1057–68.Google Scholar

Goodlad, J, Fletcher, CDM. Solitary fibrous tumor arising at unusual sites: analysis of series. Histopathology. 1991;19:515–22.Google Scholar

Guillou, L, Gebhard, S, Coindre, JM, et al. Lipomatous hemangiopericytoma: a fat containing variant of solitary fibrous tumor? Hum Pathol. 2000a;31:1108–15.Google Scholar

Guillou, L, Gebhard, S, Coindre, JM, et al. Orbital and extraorbital giant cell angiofibroma: a giant cell rich variant of solitary fibrous tumor? Am J Surg Pathol. 2000b;24:971–9.Google Scholar

Hanau, CA, Miettinen, M. Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites. Hum Pathol. 1995;26:440–9.Google Scholar

Lee, JC, Fletcher, CD. Malignant fat-forming solitary fibrous tumor (so-called “lipomatous hemangiopericytoma”): clinicopathologic analysis of 14 cases. Am J Surg Pathol. 2011;35:1177–85.Google Scholar

Mentzel, T, Bainbridge, TC, Katenkamp, D. Solitary fibrous tumor: clinicopathological, immunohistochemical, and ultrastructural analysis of 12 cases arising in soft tissues, nasal cavity and nasopharynx, urinary bladder and prostate. Virchows Arch. 1997;430:445–53.Google Scholar

Mosquera, JM, Fletcher, CD. Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component is this dedifferentiated SFT? Am J Surg Pathol. 2009;33:1314–21.Google Scholar

Ng, TL, Gown, AM, Barry, TS, et al: Nuclear beta-catenin in mesenchymal tumors, Mod Pathol. 2005;18:68–74.Google Scholar

Nielsen, GP, O’Connell, JX, Dickersin, GR. Solitary fibrous tumor of soft tissue: A report of 15 cases, including 5 malignant examples with light microscopic, immunohistochemical, and ultrastructural data. Mod Pathol. 1997;10:1028–37.Google Scholar

Robinson, DR, Wu, YM, Kalyana-Sundaram, S, et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet. 2013;45:180–5.Google Scholar

Schweizer, L, Koelsche, C, Sahm, F, et al. Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathol. 2013;125:651–8.Google Scholar

Stacchiotti, S, Saponara, M, Frapolli, R, et al. Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour. Eur J Cancer. 2017;76:84–92.Google Scholar

Suster, S, Nascimento, AG, Miettinen, M, Sickel, JZ, Moran, CA. Solitary fibrous tumors of soft tissue. A clinicopathologic and immunohistochemical study of 12 cases. Am J Surg Pathol. 1995;19:1257–66.Google Scholar

Vallat-Decouvelaere, AV, Dry, SM, Fletcher, CDM. Atypical and malignant solitary fibrous tumors in extrathoracic locations: evidence of their comparability to intra-thoracic tumors. Am J Surg Pathol. 1998;22:1501–11.Google Scholar

van Houdt, WJ, Westerveld, CM, Vrijenhoek, JE, et al. Prognosis of solitary fibrous tumors: a multicenter study. Ann Surg Oncol. 2013 Dec;20(13):4090–5.Google Scholar

Westra, WH, Grenko, RT, Epstein, J. Solitary fibrous tumor of the lower urogenital tract: a report of five cases involving the seminal vesicles, urinary bladder, and prostate. Hum Pathol. 2000;31:63–8.Google Scholar

Witkin, GB, Rosai, J. Solitary fibrous tumor of the mediastinum. A report of 14 cases. Am J Surg Pathol. 1989;13:547–57.Google Scholar PubMed

Yang, EJ, Howitt, BE, Fletcher, CD, Nucci, MR. Solitary fibrous tumor of the female genital tract: a clinicopathologic analysis of 25 cases. Histopathology. 2017 Nov 6.Google Scholar

Antonescu, C, Leung, DH, Dudas, M, et al. Alterations of cell cycle regulators in localized synovial sarcoma: A multifactorial study with prognostic implications. Am J Pathol. 2000;156:977–83.Google Scholar

Bégueret, H, Galateau-Salle, F, Guillou, L, et al. Primary intrathoracic synovial sarcoma: a clinicopathologic study of 40 t(X;18)-positive cases from the French Sarcoma Group and the Mesopath Group. Am J Surg Pathol. 2005;29:339–46.Google Scholar

Bianchi, G, Sambri, A, Righi, A, et al. Histology and grading are important prognostic factors in synovial sarcoma. Eur J Surg Oncol. 2017;43:1733–9.Google Scholar

Clark, J, Rocques, PG, Crew, AJ, et al. Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet. 1994;7:502–7.Google Scholar

Crew, AJ, Clark, J, Fisher, C, et al. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J. 1995;14:2333–40.Google Scholar

Dei Tos, AP, Dal Cin, P, Sciot, R, et al. Synovial sarcoma of the larynx and hypopharynx. Ann Othol Rhinol Laryngol. 1998;107:1080–5.Google Scholar

Dei Tos, AP, Wadden, C, Calonje, E. Immunohistochemical demonstration of p30/32MIC2 (CD99) in synovial sarcoma. A potential cause of diagnostic confusion. Appl Immunohistochem. 1995;3:168–73.Google Scholar

Fisher, C, Folpe, AL, Hashimoto, H, Weiss, SW. Intra-abdominal synovial sarcoma: a clinicopathological study. Histopathology. 2004;45:245–53.Google Scholar

Fligman, I, Lonardo, F, Jhanwar, SC, et al. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript. Am J Pathol. 1995;147:1592–9.Google Scholar

Folpe, AL, Schmidt, RA, Chapman, D, Gown, AM. Poorly differentiated synovial sarcoma. Immunohistochemical distinction from primitive neuroectodermal tumors and high grade malignant peripheral nerve sheath tumors. Am J Surg Pathol. 1998;22:673–82.Google Scholar

Guillou, L, Benhattar, J, Bonichon, F, et al. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J Clin Oncol. 2004;22:4040–50.Google Scholar

Guillou, L, Wadden, C, Kraus, MD, et al. S-100 protein reactivity: in synovial sarcomas: A potentially frequent diagnostic pitfall. Immunohistochemical analysis of 100 cases. Appl Immunohistochem. 1996;4:167–75.Google Scholar

Hartel, PH, Fanburg-Smith, JC, Frazier, AA, et al. Primary pulmonary and mediastinal synovial sarcoma: a clinicopathologic study of 60 cases and comparison with five prior series. Mod Pathol. 2007;20:760–9.Google Scholar

Kawai, A, Woodruff, J, Healey, JH, et al. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med. 1998;338:153–60.Google Scholar

Krane, JF, Bertoni, F, Fletcher, CD. Myxoid synovial sarcoma: an underappreciated morphologic subset. Mod Pathol. 1999;12:456–62.Google Scholar

Lai, JP, Robbins, PF, Raffeld, M, et al. NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis. Mod Pathol. 2012;25:854–8.Google Scholar

Lewis, JJ, Antonescu, CR, Leung, DH, et al. Synovial sarcoma: A multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol. 2000;18:2087–94.Google Scholar

Majeste, RM, Beckman, EN. Synovial sarcoma with an overwhelming epithelial component. Cancer. 1988;61:2527–31.Google Scholar

Robbins, PF, Morgan, RA, Feldman, SA, et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol. 2011;29:917–24.Google Scholar

Shipley, J, Crew, J, Birdsall, S, et al. Interphase fluorescence in situ hybridization and reverse transcription polymerase chain reaction as a diagnostic aid for synovial sarcoma. Am J Pathol. 1996;148:559–67.Google Scholar

Spurrell, EL, Fisher, C, Thomas, JM, et al. Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital. Ann Oncol. 2005;16:437–44.Google Scholar

Suster, S, Moran, CA. Primary synovial sarcomas of the mediastinum: a clinicopathologic, immunohistochemical, and ultrastructural study of 15 cases. Am J Surg Pathol. 2005;29:569–78.Google Scholar

Terry, J, Saito, T, Subramanian, S, et al. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am J Surg Pathol. 2007;31:240–6.Google Scholar

Van de Rijn, M, Barr, FG, Collins, MH, Xiong, QB, Fisher, C. Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma. Am J Clin Pathol. 1999;112:43–9.Google Scholar

Van de Rijn, M, Barr, FG, Xiong, QB, et al. Poorly differentiated synovial sarcoma. An analysis of clinical, pathologic, and molecular genetic features. Am J Surg Pathol. 1999;23:106–12.Google Scholar

Chung, EB, Enzinger, FM. Infantile fibrosarcoma. Cancer. 1976;38:729–39.Google Scholar

Coffin, CM, Dehner, LP. Fibroblastic-myofibroblastic tumors in children and adolescents: a clinicopathologic study of 108 examples in 103 patients. Pediatr Pathol. 1991;11:569–88.Google Scholar

Coffin, CM, Jaszcz, W, O’Shea, PA, Dehner, LP. So-called congenital-infantile fibrosarcoma: does it exist and what is it? Pediatr Pathol. 1994;14:133–50.Google Scholar

Dal Cin, P, Brock, P, Casteels-Van Daele, M, et al. Cytogenetic characterization of congenital or infantile fibrosarcoma. Eur J Pediatr. 1991;150:579–81.Google Scholar

Kao, YC, Fletcher, CDM, Alaggio, R, et al. Recurrent BRAF gene fusions in a subset of pediatric spindle cell sarcomas: expanding the genetic spectrum of tumors with overlapping features with infantile fibrosarcoma. Am J Surg Pathol. 2018;42:28–38.Google Scholar

Knezevich, SR, Garnett, MJ, Pysher, TJ, et al. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma. Cancer Res. 1998;58:5046–8.Google Scholar

Knezevich, SR, McFadden, DE, Tao, W, Lim, JF, Sorensen, PH. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat Genet. 1998;18:184–7.Google Scholar

Mandahl, N, Heim, S, Rydholm, A, Willen, H, Mitelman, F. Nonrandom numerical chromosome aberrations (+8, +11, +17, +20) in infantile fibrosarcoma. Cancer Genet Cytogenet. 1989;40:137–9.Google Scholar

Rubin, BP, Chen, CJ, Morgan, TW, et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol. 1998;153:1451–8.Google Scholar

Sheng, WQ, Hisaoka, M, Okamoto, S, et al. Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues. Am J Clin Pathol. 2001;115: 348–55.Google Scholar

Soule, EH, Pritchard, DJ. Fibrosarcoma in infants and children: a review of 110 cases. Cancer. 1977;40:1711–21.Google Scholar

Brooks, JSJ, Freeman, M, Enterline, HT. Malignant “triton” tumors. Natural history and immunohistochemistry of nine new cases with literature review. Cancer. 1985;55:2543–9.Google Scholar

Ch’ng, ES, Hoshida, Y, Iizuka, N, et al. Composite malignant pheochromocytoma with malignant peripheral nerve sheath tumour: a case with 28 years of tumour-bearing history. Histopathology. 2007;51:420–2.Google Scholar

D’Agostino, AN, Soule, EH, Miller, RH. Primary malignant neoplasms of nerves (malignant neurilemmomas) in patients without manifestations of multiple neurofibromatosis (von Recklinghausen’s disease). Cancer. 1963a;16:1003–14.Google Scholar

D’Agostino, AN, Soule, EH, Miller, RH. Sarcomas of peripheral nerves and somatic soft tissues associated with multiple neurofibromatosis (von Recklinghausen’s disease). Cancer. 1963b;16:1015–27.Google Scholar

Daimaru, Y, Hashimoto, H, Enjoji, M. Malignant “triton” tumors: a clinicopathologic and immunohistochemical study of nine cases. Hum Pathol. 1984;15:768–78.Google Scholar

Ducatman, BS, Scheithauer, BW, Piepgras, DG, Reiman, HM, Ilstrup, DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986;57:215–26.Google Scholar

Ferner, RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol. 2007 6:340–51.Google Scholar

Fritchie, KJ, Jin, L, Wang, X, et al. Fusion gene profile of biphenotypic sinonasal sarcoma: an analysis of 44 cases. Histopathology. 2016;69:930–6.Google Scholar

Ghosh, BC, Gosh, L, Huvos, AG, et al. Malignant schwannoma. A clinicopathologic study. Cancer. 1973;31:184–90Google Scholar

Guccion, JG, Enzinger, FM. Malignant schwannoma associated with von Recklinghausen’s neurofibromatosis. Virchows Arch [A]. 1979;383:43–57.Google Scholar

Huang, SC, Ghossein, RA, Bishop, JA, et al. Novel PAX3-NCOA1 fusions in biphenotypic sinonasal sarcoma with focal rhabdomyoblastic differentiation. Am J Surg Pathol. 2016;40:51–9.Google Scholar

King, AA, Debaun, MR, Riccardi, VM, et al. Malignant peripheral nerve sheath tumors in neurofibromatosis 1. Am J Med Genet. 2000;93:388–92.Google Scholar

Lewis, JT, Oliveira, AM, Nascimento, AG, et al. Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol. 2012;36:517–25.Google Scholar

Miettinen, MM, Antonescu, CR, Fletcher, CDM, et al. Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview. Hum Pathol. 2017;67:1–10.Google Scholar

Schaefer, IM, Fletcher, CD, Hornick, JL. Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics. Mod Pathol. 2016;29:4–13.Google Scholar

Sorensen, SA, Mulvihill, JJ, Nielsen, A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Eng J Med. 1986;314:1010–15.Google Scholar

Wang, X, Bledsoe, KL, Graham, RP, et al. Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nat Genet. 2014;46:666–8.Google Scholar

Wong, WJ, Lauria, A, Hornick, JL, et al. Alternate PAX3-FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma. Genes Chromosomes Cancer. 2016;55:25–9.Google Scholar

Woodruff, JM, Godwin, TA, Erlandson, RA, Susin, M, Martini, N. Cellular schwannoma: a variety of schwannoma sometimes mistaken for a malignant tumor. Am J Surg Pathol. 1981;5:733–44.Google Scholar

Woodruff, JM, Perino, G. Non germ cell or teratomatous malignant tumors showing additional rhabdomyoblastic differentiation, with emphasis on the malignant Triton tumor. Semin Diagn Pathol. 1994;11:69–81.Google Scholar

Creytens, D, Mentzel, T, Ferdinande, L, et al. “Atypical” pleomorphic lipomatous tumor: a clinicopathologic, immunohistochemical and molecular study of 21 cases, emphasizing its relationship to atypical spindle cell lipomatous tumor and suggesting a morphologic spectrum (atypical spindle cell/pleomorphic lipomatous tumor. Am J Surg Pathol. 2017;41:1443–55.Google Scholar

Creytens, D, van Gorp, J, Savola, S, et al. Atypical spindle cell lipoma: a clinicopathologic, immunohistochemical, and molecular study emphasizing its relationship to classical spindle cell lipoma. Virchows Arch. 2014;465:97–108.Google Scholar

Dei Tos, AP, Mentzel, T, Newman, PL, Fletcher, CD. Spindle cell liposarcoma, a hitherto unrecognized variant of liposarcoma. Analysis of six cases. Am J Surg Pathol. 1994;18:913–21.CrossRef Google Scholar PubMed

Mariño-Enriquez, A, Nascimento, AF, Ligon, AH, Liang, C, Fletcher, CD. Atypical spindle cell lipomatous tumor: clinicopathologic characterization of 232 cases demonstrating a morphologic spectrum. Am J Surg Pathol. 2017;41:234–44.Google Scholar

Alaggio, R, Zhang, L, Sung, YS, et al. A molecular study of pediatric spindle and sclerosing rhabdomyosarcoma: identification of novel and recurrent VGLL2-related fusions in infantile cases. Am J Surg Pathol. 2016;40:224–35.Google Scholar

Cavazzana, AO, Schmidt, D, Ninfo, V, et al. Spindle cell rhabdomyosarcoma. A prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol. 1992;16:229–35.Google Scholar

Kohsaka, S, Shukla, N, Ameur, N, et al. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3 K-AKT pathway mutations. Nat Genet. 2014;46:595–600.Google Scholar

Mosquera, JM, Sboner, A, Zhang, L, et al. Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma. Genes Chromosomes Cancer. 2013;52:538–50.Google Scholar

Nascimento, AF, Fletcher, CD. Spindle cell rhabdomyosarcoma in adults. Am J Surg Pathol. 2005;29:1106–13.Google Scholar

Szuhai, K, de Jong, D, Leung, WY, Fletcher, CD, Hogendoorn, PC. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma. J Pathol. 2014;23:300–7.Google Scholar

Dewaele, B, Floris, G, Finalet-Ferreiro, J, et al. Coactivated platelet-derived growth factor receptor{alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma. Cancer Res. 2010;70:7304–14.Google Scholar

Neuville, A, Collin, F, Bruneval, P, et al. Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas. Am J Surg Pathol. 2014;38:461–9.Google Scholar

Sebenik, M, Ricci, A Jr, DiPasquale, B, et al. Undifferentiated intimal sarcoma of large systemic blood vessels: report of 14 cases with immunohistochemical profile and review of the literature. Am J Surg Pathol. 2005;29:1184–93.Google Scholar